Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bars13 (1 trial)
acetazolamide (diamox) (1 trial)
ad-214 (1 trial)
adx-324 (1 trial)
aer-01 (1 trial)
alt-100 (1 trial)
apb-r3 (1 trial)
ath-063 (1 trial)
bmb-101 (1 trial)
bwc0977 (1 trial)
dronabinol (marinol) (1 trial)
edaravone (radicava) (1 trial)
epetraborole (1 trial)
Getagozumab (1 trial)
gma106 (1 trial)
hzvsf-v13 (1 trial)
mdi-1228 (1 trial)
np-011 (1 trial)
qg101-23-0 (1 trial)
rabeprazole (pariet) (1 trial)
rbn-3143 (1 trial)
rifampin (1 trial)
smp-100 (2 trials)
sr419 (1 trial)
surufatinib (1 trial)
tetrahydrocannabinol (1 trial)
trichomylin (1 trial)
Hypertension (Phase 1)
Respiratory Syncytial Virus Infections (Phase 2)
Trials (24 total)
Trial APIs (27 total)